Education
About Us
Working with TipRanks
Follow Us
Alligator Bioscience AB (SE:ATORX)
:ATORX
Alg.Apv-527
Solid Tumor
Phase I/II
Recruiting
ALG.APV-527 First-in-human Study
Feb 26, 2023
―
Cd40 Agonist Mitazalimab In Combination With Chemotherapy
Metastatic Pancreatic Ductal Adenocarcinoma
Phase I/II
Active Not Recruiting
Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients
May 06, 2021
―
Ator-1017
Solid Tumor, Neoplasms
Phase I
Completed
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017
Oct 08, 2019
―
Ator-1015
Solid Tumor, Neoplasms
Phase I
Completed
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015
Dec 14, 2018
―
Adc-1013
Neoplasms, Solid Tumors
Phase I
Completed
ADC-1013 First-in-Human Study
Feb 16, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alligator Bioscience AB (ATORX) have in its pipeline
ATORX is currently developing the following drugs: Alg.Apv-527, Cd40 Agonist Mitazalimab In Combination With Chemotherapy, Ator-1017. These drug candidates are in various stages of clinical development as the company works toward FDA approval.